US2011165177A1PendingUtilityA1
Methods of Modulating Immunity
Est. expiryNov 14, 2023(expired)· nominal 20-yr term from priority
A61P 3/10A61P 37/06A61P 37/02A61P 37/00A61P 27/14A61P 29/00A61P 25/00A61P 19/02A61P 1/04A61P 17/06A61K 2039/505C07K 2317/54C07K 16/2809A61K 2039/542
51
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The invention provides novel methods of administering anti-CD3 antibodies, e.g., via oral or mucosal delivery. The invention also provides methods of treating, preventing, or delaying the onset of autoimmune disorders by oral or mucosal administration of anti-CD3 antibodies. Finally, the invention provides compositions including anti-CD3 antibodies, suitable for oral or mucosal administration.
Claims
exact text as granted — not AI-modified1 . A method of treating, preventing, or delaying the onset of an autoimmune disease in a subject, the method comprising administering to the subject an anti-CD3 antibody, wherein the administering is oral or mucosal.
Join the waitlist — get patent alerts
Track US2011165177A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.